kinetin has been researched along with thapsigargin in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
Müllbacher, A; Waring, P | 1 |
2 other study(ies) available for kinetin and thapsigargin
Article | Year |
---|---|
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
Cell death mediated by alloreactive cytotoxic T cells via the granule exocytosis or the Fas pathway is independent of p34cdc2 kinase: Fas dependent killing of cells arrested in the cell cycle.
Topics: Animals; Apoptosis; CDC28 Protein Kinase, S cerevisiae; Cell Cycle; Cell Separation; Cytotoxicity Tests, Immunologic; DNA Fragmentation; Enzyme Inhibitors; Exocytosis; fas Receptor; Flow Cytometry; Killer Cells, Natural; Kinetin; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Knockout; Purines; T-Lymphocytes, Cytotoxic; Thapsigargin; Tumor Cells, Cultured | 2001 |